127 related articles for article (PubMed ID: 11836608)
1. Changes in natural killer cell activity by external radiotherapy and/or brachytherapy.
Yamazaki H; Yoshioka Y; Inoue T; Tanaka E; Nishikubo M; Sato T; Ishida T; Nakamura H; Inoue T
Oncol Rep; 2002; 9(2):359-63. PubMed ID: 11836608
[TBL] [Abstract][Full Text] [Related]
2. Effect of bitter melon (Momordica charantia Linn) on level and function of natural killer cells in cervical cancer patients with radiotherapy.
Pongnikorn S; Fongmoon D; Kasinrerk W; Limtrakul PN
J Med Assoc Thai; 2003 Jan; 86(1):61-8. PubMed ID: 12678140
[TBL] [Abstract][Full Text] [Related]
3. Urinary 8-hydroxy-2'-deoxyguanosine excretion as a biomarker for estimating DNA oxidation in patients undergoing external radiotherapy and/or brachytherapy.
Yamazaki H; Inoue T; Koizumi M; Tanaka E; Yoshioka Y; Nakamura H; Shuo X; Inoue T
Oncol Rep; 2005 May; 13(5):847-51. PubMed ID: 15809748
[TBL] [Abstract][Full Text] [Related]
4. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
[TBL] [Abstract][Full Text] [Related]
5. Early inhibition of natural and interferon-activated killers in endometrial cancer patients treated with local radiotherapy.
Mandeville R; Sidrac-Ghali S; Ajdukovic I; Vidal D; Ayoub J
Cancer Detect Prev; 1987; 10(1-2):129-39. PubMed ID: 2436775
[TBL] [Abstract][Full Text] [Related]
6. [The effect of sera of breast cancer patients on NK cell activity].
Konjević G; Spuzić I
Srp Arh Celok Lek; 1995; 123(9-10):227-31. PubMed ID: 17974436
[TBL] [Abstract][Full Text] [Related]
7. Radiotherapy-induced changes of peripheral blood lymphocyte subpopulations in cervical cancer patients: relationship to clinical response.
Eric A; Juranic Z; Tisma N; Plesinac V; Borojevic N; Jovanovic D; Milovanovic Z; Gavrilovic D; Ilic B
J BUON; 2009; 14(1):79-83. PubMed ID: 19373951
[TBL] [Abstract][Full Text] [Related]
8. [External irradiation combined with intracavitary brachytherapy for esophageal cancer].
Zhou G; Chen G; Cui S; Sun J; Yang D
Zhonghua Wai Ke Za Zhi; 2001 Dec; 39(12):925-7. PubMed ID: 16201172
[TBL] [Abstract][Full Text] [Related]
9. [A clinical study of a multiregression analysis on the NK activity and related clinical factors in patients with lung cancer].
Ogata H; Miyoshi T; Itami J; Anzai Y; Yoshikawa K; Takizawa Y; Takano H; Yamada T; Terauchi T; Saito M
Gan No Rinsho; 1989 Apr; 35(5):554-9. PubMed ID: 2716187
[TBL] [Abstract][Full Text] [Related]
10. Intra-operative electron beam radiotherapy and abdomino-pelvic surgery for cancer: influence on immunological parameters.
Bussières E; Richaud P; Gualde N
Eur J Surg Oncol; 1992 Oct; 18(5):425-32. PubMed ID: 1426291
[TBL] [Abstract][Full Text] [Related]
11. Amifostine enhances recovery and expansion of peripheral FAS/CD95+ T- and NK-cell subpopulations during radiotherapy of patients with head-neck cancer.
Koukourakis GV; Baksevanis CN; Zambatis H; Gritzapis A; Maltezos E; Simopoulos C; Koukourakis MI
Int J Radiat Biol; 2009 Jan; 85(1):96-104. PubMed ID: 19205988
[TBL] [Abstract][Full Text] [Related]
12. Radiation therapy for prostate cancer increases subsequent risk of bladder and rectal cancer: a population based cohort study.
Nieder AM; Porter MP; Soloway MS
J Urol; 2008 Nov; 180(5):2005-9; discussion 2009-10. PubMed ID: 18801517
[TBL] [Abstract][Full Text] [Related]
13. Combined IFN-gamma-endostatin gene therapy and radiotherapy attenuates primary breast tumor growth and lung metastases via enhanced CTL and NK cell activation and attenuated tumor angiogenesis in a murine model.
Liu LL; Smith MJ; Sun BS; Wang GJ; Redmond HP; Wang JH
Ann Surg Oncol; 2009 May; 16(5):1403-11. PubMed ID: 19263173
[TBL] [Abstract][Full Text] [Related]
14. The effect of intensity-modulated radiotherapy and high dose rate brachytherapy on acute and late radiotherapy-related adverse events following chemoradiotherapy of anal cancer.
Saarilahti K; Arponen P; Vaalavirta L; Tenhunen M
Radiother Oncol; 2008 Jun; 87(3):383-90. PubMed ID: 18501454
[TBL] [Abstract][Full Text] [Related]
15. The Vienna applicator for combined intracavitary and interstitial brachytherapy of cervical cancer: clinical feasibility and preliminary results.
Dimopoulos JC; Kirisits C; Petric P; Georg P; Lang S; Berger D; Pötter R
Int J Radiat Oncol Biol Phys; 2006 Sep; 66(1):83-90. PubMed ID: 16839702
[TBL] [Abstract][Full Text] [Related]
16. An assessment of quality of life following radical prostatectomy, high dose external beam radiation therapy and brachytherapy iodine implantation as monotherapies for localized prostate cancer.
Frank SJ; Pisters LL; Davis J; Lee AK; Bassett R; Kuban DA
J Urol; 2007 Jun; 177(6):2151-6; discussion 2156. PubMed ID: 17509305
[TBL] [Abstract][Full Text] [Related]
17. Preferential apoptosis of CD56dim natural killer cell subset in patients with cancer.
Bauernhofer T; Kuss I; Henderson B; Baum AS; Whiteside TL
Eur J Immunol; 2003 Jan; 33(1):119-24. PubMed ID: 12594840
[TBL] [Abstract][Full Text] [Related]
18. [Influence of preoperative chemoradiotherapy, preoperative chemotherapy, and operation on immunity function in middle or lower rectal cancer patients].
Li YF; Yang ZB; Li Q; Li M; Xia CF
Zhonghua Yi Xue Za Zhi; 2008 Oct; 88(37):2629-32. PubMed ID: 19080711
[TBL] [Abstract][Full Text] [Related]
19. Acute genitourinary toxicity after high dose rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: Second analysis to determine the correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
Akimoto T; Katoh H; Noda SE; Ito K; Yamamoto T; Kashiwagi B; Nakano T
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):472-8. PubMed ID: 16168839
[TBL] [Abstract][Full Text] [Related]
20. Interstitial high-dose-rate brachytherapy combined with cervical dissection on head and neck cancer.
Pellizzon AC; dos Santos Novaes PE; Conte Maia MA; Ferrigno R; Fogarolli R; Salvajoli JV; Kowalski LP
Head Neck; 2005 Dec; 27(12):1035-41. PubMed ID: 16114005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
